Perceptive Capital Solutions CORP

Freenome, Inc. (formerly PCSC) filed an amendment to its 8-K to include financial statements and MD&A following its business combination, reporting significant net losses and cash burn.

Freenome's SimpleScreen CRC blood-based screening test for colorectal cancer has received FDA approval, with Abbott set to commercialize it in the U.S.

Perceptive Capital Solutions Corp announced the approval of key proposals at its July 15, 2026, extraordinary general meeting, paving the way for a business combination.

Perceptive Capital Solutions Corp has postponed its extraordinary general meeting to July 15, 2026, to allow for supplemental disclosures regarding its business combination with Freenome Holdings, Inc.

Perceptive Capital Solutions Corp (PCSC) and Freenome Holdings, Inc. announced the SEC has declared their business combination registration statement effective, with a shareholder meeting scheduled for July 9, 2026.

Perceptive Capital Solutions Corp. has extended its deadline to complete an initial business combination by one year, moving it from June 13, 2026, to June 13, 2027, following shareholder approval.

Perceptive Capital Solutions Corp files its Q2 2026 10-Q, detailing progress on its business combination with Freenome Holdings, Inc. and financial status.

Perceptive Capital Solutions Corp reported a net loss in Q1 2026 and is seeking shareholder approval to extend its business combination deadline to June 2027 to complete its proposed merger with Freenome.

Perceptive Capital Solutions Corp reported a significant drop in Q3 net income and increased operating expenses, raising substantial doubt about its ability to continue as a going concern without a timely business combination.

Perceptive Capital Solutions Corp, a blank check company, reported a net income of $754,847 for Q2 2025, primarily driven by interest earned on its Trust Account, as it continues its search for a business combination.

Perceptive Capital Solutions Corp reports a net income of $678,555 for the quarter ended March 31, 2025, driven by interest income from the Trust Account.

Perceptive Capital Solutions Corp, a blank check company, reported a net income of $981,482 for the three months ended September 30, 2024, primarily driven by interest earned on investments held in trust.

Perceptive Capital Solutions Corp (PCSC) filed its annual 10-K report for the fiscal year ended December 31, 2025, detailing its proposed business combination with Freenome and highlighting a going concern uncertainty.

Perceptive Capital Solutions Corp files its annual report on Form 10-K, detailing its blank check company status, healthcare industry focus, and financial activities for the year ended December 31, 2024.

Harlan Waksal, Former Director of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.

Kenneth Song, Former Director of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.

Perceptive Capital Solutions Holdings reported changes in beneficial ownership of Perceptive Capital Solutions Corp common stock on July 20, 2026.

Perceptive Advisors Llc and 2 others reported changes in beneficial ownership of Perceptive Capital Solutions Corp common stock on July 20, 2026.

Mark C. Mckenna, Former Director of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.

Adam Leo Stone, Former Dir, Ofc, 10% Ownr of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.

Perceptive Capital Solutions Corp is seeking shareholder approval to extend the deadline for completing a business combination from June 13, 2026, to June 13, 2027, to allow more time to finalize its announced merger with Freenome Holdings, Inc.

Perceptive Capital Solutions Corp files an amendment to its registration statement for the offering and sale of up to 8,625,000 Class A Ordinary Shares.

Perceptive Capital Solutions Corp, a newly formed blank check company with ties to Perceptive Advisors, aims to raise $75 million in an initial public offering targeting the healthcare sector.

RA Capital Management, L.P. and associated entities have filed an amendment to their Schedule 13D, reporting their beneficial ownership of Freenome, Inc. common stock following a business combination and PIPE financing.

RA Capital Management and its affiliates have increased their stake in Perceptive Capital Solutions Corp and are supporting its merger with Freenome Holdings, Inc., including a significant PIPE financing.

ADAR1 Capital Management, LLC, along with related entities and Daniel Schneeberger, have updated their beneficial ownership filings for Freenome, Inc., reporting a combined 8.3% stake as of June 30, 2026.

Highbridge Capital Management, LLC reports a change in beneficial ownership of Freenome, Inc. common stock as of June 30, 2026.

Freenome, Inc. has filed an amendment to its Schedule 13G, with IPConcept (Luxembourg) S.A. and BIT Global Technology Opportunities SICAV-FIS reporting zero shares beneficially owned.

683 Capital Management, LLC, 683 Capital Partners, LP, and Ari Zweiman have filed an amendment to Schedule 13G, reporting zero beneficial ownership of Perceptive Capital Solutions Corp. Class A ordinary shares.

BIT Capital GmbH has filed a Schedule 13G, reporting beneficial ownership of 1.2% of Freenome, Inc.'s Class A Ordinary Shares as of June 30, 2026.

Several entities affiliated with Andreessen Horowitz have filed a Schedule 13G, reporting beneficial ownership of Freenome, Inc. common stock.